ACE2 and nonpapillary renal cell carcinoma: In conclusion, the present study shows that ACE in tumor vessels and APA, ACE2 and NEP/CD10 in tumor cells are differentially expressed in different renal tumor subtypes, and that the presence/abscense of these enzymes is significantly associated with tumor aggressiveness and poor outcome of patients with CCRCC.